1 - 25 of 49 results for author:"Huo L." in Literature citations
Results Customize
› Repeat search in UniProtKB (75)
| Synthetic biotechnology to study and engineer ribosomal bottromycin biosynthesis. Huo L., Rachid S., Stadler M., Wenzel S.C., Muller R. Chem. Biol. 19:1278-1287(2012) · UniProtKB (33) |
| The CC1-FHA tandem as a central hub for controlling the dimerization and activation of kinesin-3 KIF1A. Huo L., Yue Y., Ren J., Yu J., Liu J., Yu Y., Ye F., Xu T., Zhang M., Feng W. Structure 20:1550-1561(2012) · Mapped (3) |
| Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. Yu Y.L., Chou R.H., Wu C.H., Wang Y.N., Chang W.J., Tseng Y.J., Chang W.C., Lai C.C., Lee H.J., Huo L. et al. J. Biol. Chem. 287:31015-31026(2012) · Mapped (22) |
| A novel tissue inhibitor of metalloproteinase in blood clam Tegillarca granosa: molecular cloning, tissue distribution and expression analysis. Wang Q., Bao Y., Huo L., Gu H., Lin Z. Fish Shellfish Immunol. 33:645-651(2012) · UniProtKB (1) |
| Evidence for a dual role of an active site histidine in alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase. Huo L., Fielding A.J., Chen Y., Li T., Iwaki H., Hosler J.P., Chen L., Hasegawa Y., Que L. Jr., Liu A. Biochemistry 51:5811-5821(2012) · UniProtKB (1) |
| SGK3 is associated with estrogen receptor expression in breast cancer. Xu J., Wan M., He Q., Bassett R.L. Jr., Fu X., Chen A.C., Shi F., Creighton C.J., Schiff R., Huo L. et al. Breast Cancer Res. Treat. 134:531-541(2012) · Mapped (4) |
| Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. Wang Z., Meng C.J., Shen X.M., Shu Z., Ma C., Zhu G.Q., Liu H.X., He W.C., Sun X.B., Huo L. et al. J. Mol. Neurosci. 48:273-280(2012) · Mapped (2) |
| The crosstalk of mTOR/S6K1 and Hedgehog pathways. Wang Y., Ding Q., Yen C.J., Xia W., Izzo J.G., Lang J.Y., Li C.W., Hsu J.L., Miller S.A., Wang X. et al. Cancer Cell 21:374-387(2012) · Mapped (8) |
| Over-expression of leptin receptors in hypothalamic POMC neurons increases susceptibility to diet-induced obesity. Gamber K.M., Huo L., Ha S., Hairston J.E., Greeley S., Bjorbaek C. PLoS ONE 7:e30485-e30485(2012) · Mapped (5) |
| Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Li C.W., Xia W., Huo L., Lim S.O., Wu Y., Hsu J.L., Chao C.H., Yamaguchi H., Yang N.K., Ding Q. et al. Cancer Res. 72:1290-1300(2012) · Mapped (25) |
| Unusual carbon fixation gives rise to diverse polyketide extender units. Quade N., Huo L., Rachid S., Heinz D.W., Muller R. Nat. Chem. Biol. 8:117-124(2012) · UniProtKB (1) |
| Human protein-disulfide isomerase is a redox-regulated chaperone activated by oxidation of domain a'. Wang C., Yu J., Huo L., Wang L., Feng W., Wang C.C. J. Biol. Chem. 287:1139-1149(2012) · Mapped (5) |
| APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. Ding Q., Chang C.J., Xie X., Xia W., Yang J.Y., Wang S.C., Wang Y., Xia J., Chen L., Cai C. et al. J. Clin. Invest. 121:4526-4536(2011) · Mapped (12) |
| Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Gong Y., Huo L., Liu P., Sneige N., Sun X., Ueno N.T., Lucci A., Buchholz T.A., Valero V., Cristofanilli M. Cancer 117:5476-5484(2011) · Mapped (9) |
| Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Yao H., Ng S.S., Huo L.F., Chow B.K., Shen Z., Yang M., Sze J., Ko O., Li M., Yue A. et al. Mol. Cancer Ther. 10:1082-1092(2011) · Mapped (12) |
| Contribution of the Akt2 gene to type 2 diabetes in the Chinese Han population. Sun X.Q., Luo Y.Y., An L.W., Chu L., Huo L.L., Han X.Y., Zhou X.H., Ren Q., Ji L.N. Chin. Med. J. 124:725-728(2011) · Mapped (8) |
| RRP22: a novel neural tumor suppressor for astrocytoma. Chen R., Yang L., Fang J., Huo L., Zhang M., Chen F., Liu J., Wu J., Wang Y. Med. Oncol. 29:332-339(2012) · Mapped (1) |
| Cdc42-dependent formation of the ZO-1/MRCKbeta complex at the leading edge controls cell migration. Huo L., Wen W., Wang R., Kam C., Xia J., Feng W., Zhang M. |
| Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6. Huo L., Li D., Sun X., Shi X., Karna P., Yang W., Liu M., Qiao W., Aneja R., Zhou J. J. Biol. Chem. 286:9280-9286(2011) · Mapped (17) |
| Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. Song H., Li C.W., Labaff A.M., Lim S.O., Li L.Y., Kan S.F., Chen Y., Zhang K., Lang J., Xie X. et al. Biochem. Biophys. Res. Commun. 404:68-73(2011) · Mapped (19) |
| Cdc14p resets the competency of replication licensing by dephosphorylating multiple initiation proteins during mitotic exit in budding yeast. Zhai Y., Yung P.Y., Huo L., Liang C. J. Cell. Sci. 123:3933-3943(2010) · Mapped (9) |
| The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. Wang Y.N., Yamaguchi H., Huo L., Du Y., Lee H.J., Lee H.H., Wang H., Hsu J.M., Hung M.C. J. Biol. Chem. 285:38720-38729(2010) · Mapped (21) |
| Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B. Sun L., Gao J., Huo L., Sun X., Shi X., Liu M., Li D., Zhang C., Zhou J. J. Pathol. 221:425-432(2010) · Mapped (5) |
| CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Gao J., Sun L., Huo L., Liu M., Li D., Zhou J. Blood 115:4130-4137(2010) · UniProtKB (2) |
| Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls. Miller A., Vo H., Huo L., Roca C., Schmidt P.J., Rubinow D.R. J Psychiatr Res 44:788-794(2010) · Mapped (58) |